Type
[The 67th General meeting of Japanese Leprosy Association and the 6th co-medical meeting of Japanese Leprosy Association. May 13-14, 1994. Morioka City, Japan. Abstracts]. Nihon Rai Gakkai zasshi. 1994;63 Suppl:1-174.
View
Type
Crawford. Use of thalidomide in leprosy. Adverse drug reactions and toxicological reviews. 1994;13(4):177-92.
View
Type
Giedlin, Zimmerman. The use of recombinant human interleukin-2 in treating infectious diseases. Current opinion in biotechnology. 1993;4(6):722-6.
View
Type
Malik, Kher, Kumar, Kaur. Impaired cough-receptor function in leprosy. Lancet (London, England). 1978;1(8073):1094-5.
View
Type
Ward, Goralnick, Bullock. Defective leukotaxis in patients with lepromatous leprosy. The Journal of laboratory and clinical medicine. 1976;87(6):1025-32.
View
Type
Prakken. [Forerunners of the modern dermatologist]. Nederlands tijdschrift voor geneeskunde. 1976;120(20):886-91.
View
Type
Spaced clofazimine therapy of lepromatous leprosy. The American journal of tropical medicine and hygiene. 1976;25(3):437-44.
View
Type
Skinsnes, Matsuo. Hyaluronic acid, B-glucuronidase, vitamin C and the immune defect in leprosy. International journal of dermatology. 1976;15(4):286-9.
View
Type
Backe, Charlesworth, Garcia. Letter: IgM deposits in tuberculoid leprosy. Archives of dermatology. 1976;112(4):557-8.
View
Type
Levy. Bactericidal action of dapsone against Mycobacterium leprae in mice. Antimicrobial agents and chemotherapy. 1976;9(4):614-7.
View